<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01903564</url>
  </required_header>
  <id_info>
    <org_study_id>2013-0362</org_study_id>
    <secondary_id>R01HL063174</secondary_id>
    <nct_id>NCT01903564</nct_id>
  </id_info>
  <brief_title>Fetal and Neonatal Magnetophysiology</brief_title>
  <official_title>Fetal and Neonatal Magnetophysiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shared Medical Technology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fetal research and clinical practice has been hampered by a lack of suitable investigational
      techniques. Currently, ultrasound is the only widely used method of studying fetal anatomy
      and physiology, but it has significant limitations for assessment of cardiac rhythm. The
      proposed study will allow us to investigate fetal magnetocardiography (fMCG) as a new tool
      for the study of normal and abnormal fetal heart rate and rhythm, with a goal of
      demonstrating probable benefit from use of the device in patients with serious fetal
      arrhythmia. We propose a study that will last 1-2 years and will provide data to aid in
      assessing the safety and effectiveness of fMCG for diagnosis and management of patients with
      abnormal fetal heart rate and rhythm. We hope that the data from the study will support a
      Humanitarian Device Exemption (HDE) application for the subject device. The safety and
      efficacy study designs are described below. High-risk subjects will undergo echocardiography
      as part of their routine clinical management, and our results will be compared to the
      echocardiography results, as well as with postnatal ECG, when available. (Since many
      arrhythmias resolve prior to birth, either due to resolution of disease or due to treatment,
      only a limited number of diseases allow postnatal comparison). For rhythms that persist after
      birth, the diagnostic utility of fMCG and echocardiography will be assessed by computing the
      sensitivity (Sn) and specificity (Sp) relative to postnatal ECG for the following prenatal
      modalities: (i) the fMCG, (ii) the original (referral) echo, (iii) if available, the in-lab
      echocardiogram at the time of the fMCG study. Secondary endpoints will assess changes in
      diagnosis and in clinical management due to the additional information provided by fMCG,
      compared to the information provided by echocardiography alone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Percentage of Subjects Experiencing Symptoms</measure>
    <time_frame>15-40 weeks' gestation</time_frame>
    <description>Percentage of subjects experiencing symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Subjects Experiencing Adverse Events Unrelated to Device</measure>
    <time_frame>15 weeks' gestation till up to 1 month after birth</time_frame>
    <description>Percentage of subjects experiencing adverse events unrelated to device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Concordance of fMCG and Postnatal ECG for Diagnosis of Long QT Syndrome</measure>
    <time_frame>Birth to age 1 week</time_frame>
    <description>Number of Participants with Concordance of fMCG and Postnatal ECG for Diagnosis of Long QT Syndrome based on measurement of rate-corrected QT interval (QTc)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Subjects Experiencing Adverse Events Related to Device</measure>
    <time_frame>15 weeks' gestation till up to 1 month after birth</time_frame>
    <description>Percentage of Subjects Experiencing Adverse Events Related to Device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Fetuses With a Family History of Long QT Syndrome Who a Change in Diagnosis Due to fMCG</measure>
    <time_frame>15 weeks' gestation to birth</time_frame>
    <description>Percentage of fetuses with a family history of long QT syndrome who a change in diagnosis due to fMCG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Fetuses With a Family History of Long QT Syndrome Who Had a Change in Management Due to fMCG</measure>
    <time_frame>15 weeks' gestation to birth</time_frame>
    <description>Percentage of fetuses with a family history of long QT syndrome who had a change in management due to fMCG</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">39</enrollment>
  <condition>Fetal Arrhythmia</condition>
  <condition>Abnormality in Fetal Heart Rate or Rhythm</condition>
  <condition>Long QT Syndrome</condition>
  <arm_group>
    <arm_group_label>normal</arm_group_label>
    <description>pregnant women with uncomplicated pregnancies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high-risk</arm_group_label>
    <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>magnetocardiography</intervention_name>
    <description>recording of magnetic heart activity</description>
    <arm_group_label>normal</arm_group_label>
    <arm_group_label>high-risk</arm_group_label>
    <other_name>MCG</other_name>
    <other_name>fetal magnetocardiography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>postnatal ECG</intervention_name>
    <description>postnatal ECG</description>
    <arm_group_label>high-risk</arm_group_label>
    <other_name>electrocardiography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fetal echocardiography</intervention_name>
    <description>fetal echocardiography</description>
    <arm_group_label>normal</arm_group_label>
    <arm_group_label>high-risk</arm_group_label>
    <other_name>Doppler ultrasound</other_name>
    <other_name>M-mode ultrasound</other_name>
    <other_name>2d ultrasound</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We plan to study a total of 180 subjects. Sixty will be pregnant women with uncomplicated
        pregnancies; 120 will be pregnant women with pregnancies complicated by fetal arrhythmia or
        a condition that puts the fetus at risk of fetal arrhythmia. We refer to these cases as
        &quot;high-risk&quot; due to the presence of or risk of arrhythmia to the fetus. The pregnant mothers
        will be age 18 or older. They will be studied as early as 15 weeks' gestation and may be
        asked to return, if their physician determines that additional fMCG studies are necessary.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Normal subjects: normal, healthy adult women with uncomplicated pregnancies

        High-risk cohort: The primary inclusion criterion is diagnosis of serious fetal arrhythmia,
        which is defined as sustained low or high heart rate. Low heart rate, or bradycardia, and
        high heart rate, or tachycardia, are based on normative values for gestation (usually below
        110 -120 beats/min, or above 160-180 beats/min). Intermittent bradycardia and tachycardia
        are also important to detect because these arrhythmias may become incessant over the course
        of pregnancy and have implications for patient management. Abnormal repolarization, such as
        long QT syndrome (LQTS), is another important class of arrhythmia. Fetuses with a family
        history of LQTS or a suspicious rhythm (low heart rate, intermittent AV block, or
        ventricular tachycardia) will also be studied.

        Exclusion Criteria:

        The pregnant women subjects must by aged 18 or older. High-risk subjects cannot participate
        if their physician in consultation with the lead physician of the study does not grant
        permission for them to participate in the study due to risk of travel or other reason.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Wakai, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janette Strasburger, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wisconsin-Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2013</study_first_submitted>
  <study_first_submitted_qc>July 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2013</study_first_posted>
  <results_first_submitted>April 27, 2017</results_first_submitted>
  <results_first_submitted_qc>January 9, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 7, 2018</results_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fetus</keyword>
  <keyword>fetal arrhythmia</keyword>
  <keyword>fetal heart rate</keyword>
  <keyword>long QT syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Long QT Syndrome</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Normal</title>
          <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
        </group>
        <group group_id="P2">
          <title>High-risk</title>
          <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Normal</title>
          <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
        </group>
        <group group_id="B2">
          <title>High-risk</title>
          <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="29"/>
            <count group_id="B3" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.8" lower_limit="28" upper_limit="35"/>
                    <measurement group_id="B2" value="32.0" lower_limit="24" upper_limit="42"/>
                    <measurement group_id="B3" value="31.9" lower_limit="24" upper_limit="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects Experiencing Symptoms</title>
        <description>Percentage of subjects experiencing symptoms</description>
        <time_frame>15-40 weeks' gestation</time_frame>
        <population>Symptoms include premature labor, vaginal bleeding, uterine cramping, nausea/vomiting, dizziness, dsypnea, syncope, palpitations, or fatigue during the study session.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
          </group>
          <group group_id="O2">
            <title>High-risk</title>
            <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Experiencing Symptoms</title>
          <description>Percentage of subjects experiencing symptoms</description>
          <population>Symptoms include premature labor, vaginal bleeding, uterine cramping, nausea/vomiting, dizziness, dsypnea, syncope, palpitations, or fatigue during the study session.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects Experiencing Adverse Events Unrelated to Device</title>
        <description>Percentage of subjects experiencing adverse events unrelated to device</description>
        <time_frame>15 weeks' gestation till up to 1 month after birth</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
          </group>
          <group group_id="O2">
            <title>High-risk</title>
            <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Experiencing Adverse Events Unrelated to Device</title>
          <description>Percentage of subjects experiencing adverse events unrelated to device</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Concordance of fMCG and Postnatal ECG for Diagnosis of Long QT Syndrome</title>
        <description>Number of Participants with Concordance of fMCG and Postnatal ECG for Diagnosis of Long QT Syndrome based on measurement of rate-corrected QT interval (QTc)</description>
        <time_frame>Birth to age 1 week</time_frame>
        <population>Fetuses with a family history of long QT syndrome</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
          </group>
          <group group_id="O2">
            <title>High-risk</title>
            <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Concordance of fMCG and Postnatal ECG for Diagnosis of Long QT Syndrome</title>
          <description>Number of Participants with Concordance of fMCG and Postnatal ECG for Diagnosis of Long QT Syndrome based on measurement of rate-corrected QT interval (QTc)</description>
          <population>Fetuses with a family history of long QT syndrome</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects Experiencing Adverse Events Related to Device</title>
        <description>Percentage of Subjects Experiencing Adverse Events Related to Device</description>
        <time_frame>15 weeks' gestation till up to 1 month after birth</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
          </group>
          <group group_id="O2">
            <title>High-risk</title>
            <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Experiencing Adverse Events Related to Device</title>
          <description>Percentage of Subjects Experiencing Adverse Events Related to Device</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Fetuses With a Family History of Long QT Syndrome Who a Change in Diagnosis Due to fMCG</title>
        <description>Percentage of fetuses with a family history of long QT syndrome who a change in diagnosis due to fMCG</description>
        <time_frame>15 weeks' gestation to birth</time_frame>
        <population>Fetuses with family history of LQTS</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
          </group>
          <group group_id="O2">
            <title>High-risk</title>
            <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Fetuses With a Family History of Long QT Syndrome Who a Change in Diagnosis Due to fMCG</title>
          <description>Percentage of fetuses with a family history of long QT syndrome who a change in diagnosis due to fMCG</description>
          <population>Fetuses with family history of LQTS</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Fetuses With a Family History of Long QT Syndrome Who Had a Change in Management Due to fMCG</title>
        <description>Percentage of fetuses with a family history of long QT syndrome who had a change in management due to fMCG</description>
        <time_frame>15 weeks' gestation to birth</time_frame>
        <population>Fetuses with a family history of fetal long QT syndrome</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
          </group>
          <group group_id="O2">
            <title>High-risk</title>
            <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Fetuses With a Family History of Long QT Syndrome Who Had a Change in Management Due to fMCG</title>
          <description>Percentage of fetuses with a family history of long QT syndrome who had a change in management due to fMCG</description>
          <population>Fetuses with a family history of fetal long QT syndrome</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Normal</title>
          <description>pregnant women with uncomplicated pregnancies
magnetocardiography: recording of magnetic heart activity
fetal echocardiography: fetal echocardiography</description>
        </group>
        <group group_id="E2">
          <title>High-risk</title>
          <description>pregnant women with pregnancies complicated by fetal arrhythmia or the risk of fetal arrhythmia
magnetocardiography: recording of magnetic heart activity
postnatal ECG: postnatal ECG
fetal echocardiography: fetal echocardiography</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>fetal death</sub_title>
                <description>A fetus with a severe ion channelopathy died 10 days following participation in the study. The death is believed to be unrelated to the use of the device.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Motor vehicle accident</sub_title>
                <description>Subject was driving and was rear ended at high speed by another car. OB chose to admit her over night for observation for possibility of uterine contractions. No problem in-house, sent home &lt;24 hours later.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ronald Wakai, Ph.D.</name_or_title>
      <organization>University of Wisconsin-Madison</organization>
      <phone>6082654988</phone>
      <email>rtwakai@wisc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

